IP Library Granted Patent US 9,375,223
Granted Patent B2
US 9,375,223 · App. 14/164,512 · Granted Jun 28, 2016

Methods and devices for endovascular therapy

Inventor: Michael P Wallace (Pleasanton, CA)
Assignee: CardioProlific Inc.
A61B17/2202A61B17/22004A61B17/22012A61M37/0092A61B18/245A61B2017/22014A61B2017/22015A61B2017/22018A61B2017/22039A61B2017/22082A61B2017/22088A61B2017/22098A61B2017/320088A61B2018/00029A61B2018/0212
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,375,223
App. No.
14/164,512
Granted
Jun 28, 2016
Kind
B2
Abstract

The present invention provides methods and devices for treating endovascular disease. Vibrational energy is delivered to change compliance and increase permeability at the treatment area. To improve clinical outcomes, one or more therapeutic drugs may be delivered to the treatment area.

Claims (36)

1. A method of treating vascular stenosis, comprising the steps of:

performing balloon angioplasty at a treatment area inside a vessel;

positioning a distal end of a vibrational device at the treatment area, the vibrational device having a transmission member;

propagating vibrational energy through the transmission member from a proximal transducer located outside the patient to the distal end of the vibrational device at a frequency of 1 KHZ-20 MHZ while undergoing irrigation to form surface waves at the distal end of the vibrational device;

applying the surface waves at a power of less than 20 Watts at the distal end of the vibrational device to the treatment area to change the stenosis compliance and to increase permeability of the vessel for delivery of an anti-proliferative agent, wherein the surface waves are propagated from the distal end of the vibrational device to the treatment area through irrigation liquid;

positioning a blood flow protection device at a location distal to the treatment area to prevent the anti-proliferative agent from flowing distally;

delivering the anti-proliferative agent to the treatment area using a contrast agent as a matrix within less than 60 minutes from the application of the surface waves; and

applying the therapeutic agent in the treatment area for less than 60 minutes.

2. The method of claim 1 , further including performing an interventional procedure that is selected from the group consisting of: stent placement, atherectomy, laser, ultrasound, cryoplasty, and a combination thereof.

3. The method of claim 1 , wherein the anti-proliferative agent in mixture with contrast further includes saline solution.

4. The method of claim 1 , further including delivery of longitudinal waves, transverse waves, and a combination thereof.

5. The method of claim 1 , wherein vibrational energy is propagated from the vibrational device to the treatment area in one of the following ways: through irrigation liquid in mixture with blood, through direct contact with the tissue, and combination of all.

6. The method of claim 1 , further comprising at least partially removing the anti-proliferative agent outside the body.

7. The method of claim 1 , further including the treatment of endovascular stenosis in one of the following treatment areas: arteries, veins, in-stent, grafts, fistulas, or combinations thereof.

8. The method of claim 1 , wherein the blood flow protection device is a first blood flow protection device, further including positioning a second blood flow protection device proximally to the treatment area.

9. The method of claim 8 , wherein the first and second blood flow protection devices comprise a dual balloon device having a first balloon adjacent a distal end of the treatment area and the second balloon adjacent a proximal end of the treatment area.

10. The method of claim 1 , wherein the vibrational device includes a flexible member located on the distal end.

11. The method of claim 1 , wherein the vascular stenosis includes a chronic total occlusion.

12. The method of claim 1 , wherein treating vascular stenosis includes treating vulnerable plaque.

13. The method of claim 1 , further including applying vibrational energy to the treatment area at one of the following times: before balloon angioplasty, during balloon angioplasty, after balloon angioplasty, before drug application, during drug application, after drug application, or a combination thereof.

14. The method of claim 1 , wherein the balloon angioplasty and blood flow protection are performed with the same device.

15. The method of claim 1 , wherein the anti-proliferative agent is Paclitaxel.

16. A method of treating vascular stenosis, comprising the steps of:

performing balloon angioplasty at a treatment area inside a vessel;

positioning a vibrational device at the treatment area, the vibrational device having a transmission member;

propagating vibrational energy through the transmission member from a proximal transducer located outside the patient to the distal end of the vibrational device at a frequency of 1 KHZ-20 MHZ while undergoing irrigation to form surface waves at the distal end of the vibrational device;

applying the surface waves at a power of less than 20 Watts at the distal end of the vibrational device to the treatment area to change the stenosis compliance and to increase permeability of the vessel to receive an anti-proliferative agent, wherein the surface waves are propagated from the distal end of the vibrational device to the treatment area through irrigation liquid;

delivering an anti-proliferative agent to the treatment area using a drug delivery balloon device within less than 60 minutes from the application of the surface waves; and

applying the anti-proliferative agent in the treatment area for less than 60 minutes.

17. A method of treating vascular stenosis, comprising the steps of:

performing balloon angioplasty at a treatment area inside a vessel;

positioning a vibrational device at the treatment area, the vibrational device having a transmission member;

propagating vibrational energy through the transmission member from a proximal transducer located outside the patient to the distal end of the vibrational device at a frequency of 1 KHZ-20 MHZ and a power of less than 20 Watts while undergoing irrigation to form surface waves at the distal end of the vibrational device;

applying the surface waves from the vibrational device to the treatment area to change the stenosis compliance and to increase permeability of the vessel to receive an anti-proliferative agent, wherein the surface waves are propagated from the distal end of the vibrational device to the treatment area through irrigation fluid;

delivering an anti-proliferative agent to the treatment area within less than 60 minutes from the application of the surface waves; and

delivering a drug eluting stent within less than 60 minutes from the application of the surface waves.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 8, 2016
From: WALLACE, MICHAEL P
To: CARDIOPROLIFIC INC.
Reel/Frame 038392/0062 →
Continuity (10)
Continuation In Part 13962646 · Aug 8, 2013
Continuation In Part 13625405 · Sep 24, 2012
Continuation In Part 13438221 · Apr 3, 2012
Continuation In Part 13134470 · Jun 8, 2011
Continuation In Part 12930415 · Jan 6, 2011
Continuation In Part 12925495 · Oct 22, 2010
Continuation In Part 12807129 · Aug 27, 2010
Continuation In Part 12661853 · Mar 25, 2010
Provisional Application 61278353 · Oct 6, 2009
Related Publication 20140142494A1 · May 22, 2014